Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patientsEnrico Heffler, Nunzio Crimi, Claudia Crimi et al.|Respiratory Medicine|2018Cited by 128
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registryGiorgio Walter Canonica, Massimo Triggiani, Francesco Blasi et al.|World Allergy Organization Journal|2019Cited by 119
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Κonstantinos Κostikas, Trung N. Tran et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 17
Impact of Biologic Initiation on New-onset of Corticosteroid-related Adverse Effects in Patients With Severe AsthmaDavid Price, T.N. Tran, B. Emmanuel et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0
Reply to Liu et al., Zhou et al., and Dong et al.Mohsen Sadatsafavi, Charlotte Suppli Ulrik, Trung N. Tran et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0